The goal of the proposed research is to characterize mechanisms of innate immunity in the small intestine. Cryptdins are Paneth cell defensins, microbicidal peptides that are released continually into the small intestinal lumen. The specific objectives of this proposal are focused at defining the mechanisms of cryptdin action and the regulation of their synthesis. Six mouse cryptdins have been characterized, and they are potent antimicrobial agents with selective activities against varied target microbes. In addition to the six known peptides, fourteen novel cryptdin isoforms have been predicted by genetic evidence. Cryptdins are coded by separate genes, and certain genes are expressed differentially during postnatal crypt ontogeny and along the longitudinal axis of the adult small bowel. Abundant data support the hypothesis that Paneth cell defensins are important components of mucosal immunity, and that concept will be tested by analyzing biological interactions between murine cryptdins and by characterizing the corresponding genes. To test hypotheses regarding mechanisms of Paneth cell defensin action, potential synergistic interactions between cryptdins will be investigated by quantitating the regional cryptdin isoform content of mouse small intestine, evaluating the microbicidal action of modified cryptdins isolated from the intestinal lumen, and by assaying cryptdins, both individually and in combinations that reflect their relative levels, for antimicrobial potency against a range of pathogens. Preparations of individual and combined Paneth cell defensins will be tested for potential cytotoxic effects against mammalian cell lines, and cytotoxicities will be compared with that of myeloid defensins. To investigate the role of pore-formation in the cryptdin killing mechanism, measurements will be made of the kinetics and stoichiometry of ion- permeable channel formation in lipid bilayers by cryptdins. To test hypotheses relevant to regulation of cryptdin synthesis, the primary structures of cryptdins isolated from newborn mouse small bowel will be determined, and the developmental appearance of cryptdin isoforms will be established. The relative placement and orientation of mouse cryptdin isoform genes will be established along the physical map. Finally, potential cis-acting determinants of cryptdin positional specificity will be studied by characterizing transgenic mice constructed with variable flanking and intronic regions of the cryptdin-4 gene. These studies will clarify mechanisms of Paneth cell defensin function in innate immunity by elucidating their mode of action, potential interactions, and the regulation of their synthesis in the adult and developing mouse small intestine.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK044632-05
Application #
2414818
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1993-05-01
Project End
1997-08-31
Budget Start
1997-05-01
Budget End
1997-08-31
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Cobo, Eduardo R; Holani, Ravi; Moreau, France et al. (2018) Entamoeba histolytica Alters ileal Paneth Cell Functions in Intact and Muc2 Mucin Deficiency. Infect Immun :
Tai, Kenneth P; Kamdar, Karishma; Yamaki, Jason et al. (2015) Microbicidal effects of ?- and ?-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Innate Immun 21:17-29
Mastroianni, Jennifer R; Lu, Wuyuan; Selsted, Michael E et al. (2014) Differential Susceptibility of Bacteria to Mouse Paneth Cell ?-Defensins under Anaerobic Conditions. Antibiotics (Basel) 3:493-508
Tai, Kenneth P; Le, Valerie V; Selsted, Michael E et al. (2014) Hydrophobic determinants of ?-defensin bactericidal activity. Infect Immun 82:2195-202
Patil, Amar A; Ouellette, Andre J; Lu, Wuyuan et al. (2013) Rattusin, an intestinal ?-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities. Antimicrob Agents Chemother 57:1823-31
Schmidt, Nathan W; Tai, Kenneth P; Kamdar, Karishma et al. (2012) Arginine in ?-defensins: differential effects on bactericidal activity correspond to geometry of membrane curvature generation and peptide-lipid phase behavior. J Biol Chem 287:21866-72
Tongaonkar, Prasad; Golji, Amir E; Tran, Patti et al. (2012) High fidelity processing and activation of the human ?-defensin HNP1 precursor by neutrophil elastase and proteinase 3. PLoS One 7:e32469
Mastroianni, Jennifer R; Costales, Jessica K; Zaksheske, Jennifer et al. (2012) Alternative luminal activation mechanisms for paneth cell ?-defensins. J Biol Chem 287:11205-12
Burkhardt, Amanda M; Tai, Kenneth P; Flores-Guiterrez, Juan P et al. (2012) CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol 188:6399-406
Andersson, Håkan S; Figueredo, Sharel M; Haugaard-Kedström, Linda M et al. (2012) The ?-defensin salt-bridge induces backbone stability to facilitate folding and confer proteolytic resistance. Amino Acids 43:1471-83

Showing the most recent 10 out of 27 publications